Arup Das, MD, Ph.D
Chief, Ophthalmology Division
Professor of Ophthalmology and Cell Biology & Physiology
Vice Chairman of Research, Department of Surgery
American Board of Ophthalmology
Retinal Diseases, Vitreo-retinal diseases and Surgery, Macular Diseases, Diabetic Retinopathy, Macular Degeneration
Dr Das has strong research interests in the field of diabetic retinopathy, especially the role of inflammation. He, along with Dr. Paul McGuire, PhD, has been working on the role of proteinases in retinal and choroidal angiogenesis and alteration of the blood-retinal barrier in diabetic retinopathy. His lab is examining novel therapeutic targets in retinal diseases.
Dr Das is a physician-scientist and Director of the Retina Service, who is a principal investigator on several clinical trials in diabetic retinopathy, and is also actively involved in basic science work in angiogenesis and diabetic retinopathy.
Medical College, University of Calcutta
Medical College of Ohio
University of New Mexico School of Medicine
Wayne State University
University of Southern California School of Medicine
Los Angeles, CA
Retina Society, Macula Society, American Society for Retina Specialists (ASRS), American Academy of Ophthalmology, Association for research in Vision & Ophthalmology (ARVO), International Society for Eye Research, New Mexico Ophthalmological Society (NMOS)
Gold Fellow, Association for Research in Vision & Ophthalmology (ARVO); Teacher of the Year Award, University of Pittsburgh; Outstanding Clinical Instructor Award, University of Wisconsin
Study Section Member, National Eye Institute; Member, Epidemiology of Diabetes Interventions and Complications (EDIC) Ophthalmology Working Group
McGuire PG, Rangasamy S, Maestas J, Das A Pericyte derived Sphingosine 1 phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier. Arterioscler Thromb Vasc Biol 2011 Dec 31(12):e107-15.
Rangaswamy, S, Maestas J, Srinivasan, R, McGuire, P, Das, A. A Possible Role of Angiopoietin-2 in alteration of the blood-retinal barrier in diabetic retinopathy. Invest Ophthalmol Vis Sci, 2011 Jun 1;52(6):3784-91.
Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A, Ciulla TA, Pollack JS, Lim JI, Eliot D, Campochiaro PA; READ-2 Study Group. Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study. Ophthalmol 2010; 117:2146-51.
To search for a full list of publications of Dr Das, please visit the National Library of Medicine website.